Ser144

Javascript is not enabled on this browser. This site will not work properly without Javascript.

Home > Phosphorylation Site Page: > Ser144 - MSH6 (human)

Site Information
sPtrGWVsKRLLKPy SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 50830974

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 )
Disease tissue studied:	lung cancer ( 1 ) , non-small cell lung cancer ( 1 )
Relevant cell line - cell type - tissue:	H2077 (pulmonary) ( 1 ) , H322M (pulmonary) ( 1 ) , HCC366 (pulmonary) ( 1 ) , HCC78 (pulmonary) ( 1 ) , NCI-H1395 (pulmonary) ( 1 ) , NCI-H2030 (pulmonary) ( 1 ) , NCI-H520 (squamous) ( 1 ) , PC9 (pulmonary) ( 1 )

References
1	Klammer M, et al. (2012) Phosphosignature predicts dasatinib response in non-small cell lung cancer. Mol Cell Proteomics 11, 651-68 22617229 Curated Info

Developed with grants from

and literature mining with Linguamatics

PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.